Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson's patients leukocytes

BMC Genomics

Volumn 14, Issue 1, 2013, Pages

  Soreq, Lilach ^a   Bergman, Hagai ^a,b   Israel, Zvi ^c   Soreq, Hermona ^b  

^a HEBREW UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Alternative splicing; Deep brain stimulation; Exon microarrays; Leukocytes; Nonsense Mediated decay; Parkinson's disease

Indexed keywords

DOPAMINE; MESSENGER RNA;

ARTICLE; BRAIN DEPTH STIMULATION; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE CONTROL; DISEASE COURSE; DNA DAMAGE; ELECTRODE; ELECTROSTIMULATION; EXON; FUNCTIONAL ASSESSMENT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; INFLAMMATORY DISEASE; LEUKOCYTE; MALE; NEUROSURGERY; NONSENSE MEDIATED MRNA DECAY; PARKINSON DISEASE; SYMPTOM; THERAPY EFFECT; VOLUNTEER;

ALTERNATIVE SPLICING; CASE-CONTROL STUDIES; DEEP BRAIN STIMULATION; DISEASE PROGRESSION; HUMANS; LEUKOCYTES; MALE; MODELS, MOLECULAR; NONSENSE MEDIATED MRNA DECAY; PARKINSON DISEASE; PROTEIN CONFORMATION; RNA, MESSENGER;

EID: 84880090915     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-14-478     Document Type: Article

References (85)

1. Bhuvanagiri M, Schlitter AM, Hentze MW, Kulozik AE. NMD: RNA biology meets human genetic medicine. Biochem J 2010, 430(3):365-377. 10.1042/BJ20100699, 20795950.
2. Hilleren P, Parker R. mRNA surveillance in eukaryotes: kinetic proofreading of proper translation termination as assessed by mRNP domain organization?. RNA 1999, 5(6):711-719. 10.1017/S1355838299990519, 1369798, 10376871.
3. Holbrook JA, Neu-Yilik G, Hentze MW, Kulozik AE. Nonsense-mediated decay approaches the clinic. Nat Genet 2004, 36(8):801-808. 10.1038/ng1403, 15284851.
4. Li S, Wilkinson MF. Nonsense surveillance in lymphocytes?. Immun 1998, 8(2):135-141.
5. Frischmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999, 8(10):1893-1900. 10.1093/hmg/8.10.1893, 10469842.
6. Blaschke RJ, Topfer C, Marchini A, Steinbeisser H, Janssen JW, Rappold GA. Transcriptional and translational regulation of the Leri-Weill and Turner syndrome homeobox gene SHOX. J Biol Chem 2003, 278(48):47820-47826. 10.1074/jbc.M306685200, 12960152.
7. Moriarty PM, Reddy CC, Maquat LE. Selenium deficiency reduces the abundance of mRNA for Se-dependent glutathione peroxidase 1 by a UGA-dependent mechanism likely to be nonsense codon-mediated decay of cytoplasmic mRNA. Mol Cell Biol 1998, 18(5):2932-2939. 110672, 9566912.
8. Hillman RT, Green RE, Brenner SE. An unappreciated role for RNA surveillance. Genome Biol 2004, 5(2):R8. 10.1186/gb-2004-5-2-r8, 395752, 14759258.
9. Rebbapragada I, Lykke-Andersen J. Execution of nonsense-mediated mRNA decay: what defines a substrate?. Curr Opin Cell Biol 2009, 21(3):394-402. 10.1016/j.ceb.2009.02.007, 19359157.
10. Bruno IG, Karam R, Huang L, Bhardwaj A, Lou CH, Shum EY, Song HW, Corbett MA, Gifford WD, Gecz J, et al. Identification of a microRNA that activates gene expression by repressing nonsense-mediated RNA decay. Mol Cell 2011, 42(4):500-510. 10.1016/j.molcel.2011.04.018, 3123134, 21596314.
11. Lewis BP, Green RE, Brenner SE. Evidence for the widespread coupling of alternative splicing and nonsense-mediated mRNA decay in humans. Proc Natl Acad Sci USA 2003, 100(1):189-192. 10.1073/pnas.0136770100, 140922, 12502788.
12. Lee CJ, Irizarry K. Alternative splicing in the nervous system: an emerging source of diversity and regulation. Biol Psychiatry 2003, 54(8):771-776. 10.1016/S0006-3223(03)00375-5, 14550676.
13. Lykke-Andersen J. mRNA quality control: Marking the message for life or death. Curr Biol 2001, 11(3):R88-91. 10.1016/S0960-9822(01)00036-7, 11231165.
14. Matlin AJ, Clark F, Smith CW. Understanding alternative splicing: towards a cellular code. Nat Rev Mol Cell Biol 2005, 6(5):386-398. 10.1038/nrm1645, 15956978.
15. Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet 2008, 40(12):1413-1415. 10.1038/ng.259, 18978789.
16. Chan WK, Huang L, Gudikote JP, Chang YF, Imam JS, MacLean JA, Wilkinson MF. An alternative branch of the nonsense-mediated decay pathway. EMBO J 2007, 26(7):1820-1830. 10.1038/sj.emboj.7601628, 1847659, 17363904.
17. Saltzman AL, Pan Q, Blencowe BJ. Regulation of alternative splicing by the core spliceosomal machinery. Genes Dev 2011, 25(4):373-384. 10.1101/gad.2004811, 3042160, 21325135.
18. McIlwain DR, Pan Q, Reilly PT, Elia AJ, McCracken S, Wakeham AC, Itie-Youten A, Blencowe BJ, Mak TW. Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay. Proc Natl Acad Sci USA 2010, 107(27):12186-12191. 10.1073/pnas.1007336107, 2901484, 20566848.
19. Kringelbach ML, Jenkinson N, Owen SL, Aziz TZ. Translational principles of deep brain stimulation. Nat Rev Neurosci 2007, 8(8):623-635. 10.1038/nrn2196, 17637800.
20. Fahn S. Description of Parkinson's disease as a clinical syndrome. Ann N Y Acad Sci 2003, 991:1-14.
21. Hoehn MM, Yahr MD. Parkinsonism: onset, progression and mortality. Neurol 1967, 17(5):427-442.
22. Deuschl G, Schade-Brittinger C, Krack P, Volkmann J, Schafer H, Botzel K, Daniels C, Deutschlander A, Dillmann U, Eisner W, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006, 355(9):896-908. 10.1056/NEJMoa060281, 16943402.
23. Pollak P, Fraix V, Krack P, Moro E, Mendes A, Chabardes S, Koudsie A, Benabid AL. Treatment results: Parkinson's disease. Mov Disord 2002, 17(S3):S75-S83. 10.1002/mds.10146, 11948759.
24. Hawkes CH, Del Tredici K, Braak H. A timeline for Parkinson's disease. Parkinsonism Relat Disord 2010, 16(2):79-84. 10.1016/j.parkreldis.2009.08.007, 19846332.
25. Braak H, Del Tredici K. Invited Article: Nervous system pathology in sporadic Parkinson disease. Neurol 2008, 70(20):1916-1925.
26. Obeso JA, Rodriguez-Oroz MC, Goetz CG, Marin C, Kordower JH, Rodriguez M, Hirsch EC, Farrer M, Schapira AH, Halliday G. Missing pieces in the Parkinson's disease puzzle. Nat Med 2010, 16(6):653-661. 10.1038/nm.2165, 20495568.
27. Scherzer CR, Eklund AC, Morse LJ, Liao Z, Locascio JJ, Fefer D, Schwarzschild MA, Schlossmacher MG, Hauser MA, Vance JM, et al. Molecular markers of early Parkinson's disease based on gene expression in blood. Proc Natl Acad Sci USA 2007, 104(3):955-960. 10.1073/pnas.0610204104, 1766335, 17215369.
28. Molochnikov L, Rabey JM, Dobronevsky E, Bonucelli U, Ceravolo R, Frosini D, Grunblatt E, Riederer P, Jacob C, Aharon-Peretz J, et al. A molecular signature in blood identifies early Parkinson's disease. Mol Neurodegener 2012, 7:26. 10.1186/1750-1326-7-26, 3424147, 22651796.
29. Martins M, Rosa A, Guedes LC, Fonseca BV, Gotovac K, Violante S, Mestre T, Coelho M, Rosa MM, Martin ER, et al. Convergence of miRNA expression profiling, alpha-synuclein interacton and GWAS in Parkinson's disease. PLoS One 2011, 6(10):e25443. 10.1371/journal.pone.0025443, 3189215, 22003392.
30. Buttarelli FR, Fanciulli A, Pellicano C, Pontieri FE. The dopaminergic system in peripheral blood lymphocytes: from physiology to pharmacology and potential applications to neuropsychiatric disorders. Curr Neuropharmacol 2011, 9(2):278-288. 10.2174/157015911795596612, 3131719, 22131937.
31. Blake CI, Spitz E, Leehey M, Hoffer BJ, Boyson SJ. Platelet mitochondrial respiratory chain function in Parkinson's disease. Mov Disord 1997, 12(1):3-8. 10.1002/mds.870120103, 8990047.
32. Krige D, Carroll MT, Cooper JM, Marsden CD, Schapira AH. Platelet mitochondrial function in Parkinson's disease. The Royal Kings and Queens Parkinson Disease Research Group. Ann Neurol 1992, 32(6):782-788. 10.1002/ana.410320612, 1471869.
33. Soreq L, Bergman H, Israel Z, Soreq H. Exon Arrays Reveal Alternative Splicing Aberrations in Parkinson's Disease Leukocytes. Neurodegener Dis 2011,
34. Shehadeh LA, Yu K, Wang L, Guevara A, Singer C, Vance J, Papapetropoulos S. SRRM2, a potential blood biomarker revealing high alternative splicing in Parkinson's disease. PLoS One 2010, 5(2):e9104. 10.1371/journal.pone.0009104, 2817002, 20161708.
35. Soreq L, Bergman H, Goll Y, Greenberg DS, Israel Z, Soreq H. Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leukocytes. J Cell Mol Med 2011,
36. Soreq L, Salomonis N, Bronstein M, Greenberg DS, Israel Z, Bergman H, Soreq H. Small RNA sequencing-microarray analyses in Parkinson leukocytes reveal deep brain stimulation-induced splicing changes that classify brain region transcriptomes. Front Mol Neurosci 2013, 6:10. 3652308, 23717260.
37. Sharp FR, Jickling GC, Stamova B, Tian Y, Zhan X, Liu D, Kuczynski B, Cox CD, Ander BP. Molecular markers and mechanisms of stroke: RNA studies of blood in animals and humans. J Cereb Blood Flow Metab 2011, 31(7):1513-1531. 10.1038/jcbfm.2011.45, 3137473, 21505474.
38. de Wit MC, Lequin MH, de Coo IF, Brusse E, Halley DJ, van de Graaf R, Schot R, Verheijen FW, Mancini GM. Cortical brain malformations: effect of clinical, neuroradiological, and modern genetic classification. Arch Neurol 2008, 65(3):358-366. 10.1001/archneur.65.3.358, 18332248.
39. Yang IV, Wade CM, Kang HM, Alper S, Rutledge H, Lackford B, Eskin E, Daly MJ, Schwartz DA. Identification of novel genes that mediate innate immunity using inbred mice. Genet 2009, 183(4):1535-1544.
40. Hosack DA, Dennis G, Sherman BT, Lane HC, Lempicki RA. Identifying biological themes within lists of genes with EASE. Genome Biol 2003, 4(10):R70. 10.1186/gb-2003-4-10-r70, 328459, 14519205.
41. Ayala YM, Laura De Conti S, Vázquez AD, Romano M, D'Ambrogio A, Tollervey J, Ule J, Baralle M, Buratti E, Baralle FE. TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 2010, 30(2):277-288. 3025456, 21131904.
42. Purdom E, Simpson KM, Robinson MD, Conboy JG, Lapuk AV, Speed TP. FIRMA: a method for detection of alternative splicing from exon array data. Bioinformatics 2008, 24(15):1707-1714. 10.1093/bioinformatics/btn284, 2638867, 18573797.
43. Morales-Garcia JA, Redondo M, Alonso-Gil S, Gil C, Perez C, Martinez A, Santos A, Perez-Castillo A. Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS One 2011, 6(2):e17240. 10.1371/journal.pone.0017240, 3044733, 21390306.
44. Szponar A, Kovacs G. Expression of KRT7 and WT1 differentiates precursor lesions of Wilms' tumours from those of papillary renal cell tumours and mucinous tubular and spindle cell carcinomas. Virchows Arch 2012,
45. Brouckaert P, Libert C. Differential response of a (2)-macroglobulin-deficient mice in models of lethal TNF-induced inflammation. Eur Cytokine Netw 2001, 11(4):597-601.
46. Massabeau C, Sigal-Zafrani B, Belin L, Savignoni A, Richardson M, Kirova YM, Cohen-Jonathan-Moyal E, Megnin-Chanet F, Hall J, Fourquet A. The fibroblast growth factor receptor 1 (FGFR1), a marker of response to chemoradiotherapy in breast cancer?. Breast Cancer Res Treat 2012,
47. Dennis G, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 2003, 4(5):P3. 10.1186/gb-2003-4-5-p3, 12734009.
48. Soreq L, Ben-Shaul Y, Israel Z, Bergman H, Soreq H. Meta-analysis of genetic and environmental Parkinson's disease models reveals a common role of mitochondrial protection pathways. Neurobiol Dis 2012, 45(3):1018-1030. 10.1016/j.nbd.2011.12.021, 22198569.
49. Moran LB, Graeber MB. Towards a pathway definition of Parkinson's disease: a complex disorder with links to cancer, diabetes and inflammation. Neurogenet 2008, 9(1):1-13.
50. Lareau LF, Green RE, Bhatnagar RS, Brenner SE. The evolving roles of alternative splicing. Curr Opin Struct Biol 2004, 14(3):273-282. 10.1016/j.sbi.2004.05.002, 15193306.
51. Morrison M, Harris KS, Roth MB. smg mutants affect the expression of alternatively spliced SR protein mRNAs in Caenorhabditis elegans. Proc Natl Acad Sci USA 1997, 94(18):9782-9785. 10.1073/pnas.94.18.9782, 23268, 9275202.
52. Vilardell J, Chartrand P, Singer RH, Warner JR. The odyssey of a regulated transcript. RNA 2000, 6(12):1773-1780. 10.1017/S135583820000145X, 1370047, 11142377.
53. Hilleren P, Parker R. Mechanisms of mRNA surveillance in eukaryotes. Annu Rev Genet 1999, 33:229-260. 10.1146/annurev.genet.33.1.229, 10690409.
54. Chang JC, Kan YW. beta 0 thalassemia, a nonsense mutation in man. Proc Natl Acad Sci USA 1979, 76(6):2886-2889. 10.1073/pnas.76.6.2886, 383714, 88735.
55. Huang L, Wilkinson MF. Regulation of nonsense-mediated mRNA decay. Wiley Interdiscip Rev RNA 2012,
56. Ochs MJ, Sorg BL, Pufahl L, Grez M, Suess B, Steinhilber D. Post-Transcriptional Regulation of 5-Lipoxygenase mRNA Expression via Alternative Splicing and Nonsense-Mediated mRNA Decay. PLoS One 2012, 7(2):e31363. 10.1371/journal.pone.0031363, 3283622, 22363630.
57. Pan Q, Saltzman AL, Kim YK, Misquitta C, Shai O, Maquat LE, Frey BJ, Blencowe BJ. Quantitative microarray profiling provides evidence against widespread coupling of alternative splicing with nonsense-mediated mRNA decay to control gene expression. Genes Dev 2006, 20(2):153-158. 10.1101/gad.1382806, 1356107, 16418482.
58. Tanner CM, Goldman SM. Epidemiology of Parkinson's disease. Neurol Clin 1996, 14(2):317-335. 10.1016/S0733-8619(05)70259-0, 8827174.
59. Dorsey ER, Constantinescu R, Thompson JP, Biglan KM, Holloway RG, Kieburtz K, Marshall FJ, Ravina BM, Schifitto G, Siderowf A, et al. Projected number of people with Parkinson disease in the most populous nations, 2005 through 2030. Neurol 2007, 68(5):384-386.
60. Cooper TA, Wan L, Dreyfuss G. RNA and disease. Cell 2009, 136(4):777-793. 10.1016/j.cell.2009.02.011, 2866189, 19239895.
61. Licatalosi DD, Darnell RB. Splicing regulation in neurologic disease. Neuron 2006, 52(1):93-101. 10.1016/j.neuron.2006.09.017, 17015229.
62. Lefebvre S, Burglen L, Reboullet S, Clermont O, Burlet P, Viollet L, Benichou B, Cruaud C, Millasseau P, Zeviani M, et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80(1):155-165. 10.1016/0092-8674(95)90460-3, 7813012.
63. Zhang Z, Lotti F, Dittmar K, Younis I, Wan L, Kasim M, Dreyfuss G. SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 2008, 133(4):585-600. 10.1016/j.cell.2008.03.031, 2446403, 18485868.
64. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, Vande Velde C, Bouchard JP, Lacomblez L, Pochigaeva K, Salachas F, et al. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 2008, 40(5):572-574. 10.1038/ng.132, 18372902.
65. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Sci 2008, 319(5870):1668-1672.
66. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Sci 2009, 323(5918):1208-1211.
67. Zhang C, Frias MA, Mele A, Ruggiu M, Eom T, Marney CB, Wang H, Licatalosi DD, Fak JJ, Darnell RB. Integrative modeling defines the Nova splicing-regulatory network and its combinatorial controls. Sci 2010, 329(5990):439-443.
68. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, Donohue JP, Hall MP, Shiue L, Swanson MS, Thornton CA, et al. Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 2010, 17(2):187-193. 10.1038/nsmb.1720, 2852634, 20098426.
69. Liu N, Landreh M, Cao K, Abe M, Hendriks GJ, Kennerdell JR, Zhu Y, Wang LS, Bonini NM. The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila. Nat 2012, 482(7386):519-523.
70. Broadway JM, Holtzheimer PE, Hilimire MR, Parks NA, Devylder JE, Mayberg HS, Corballis PM. Frontal Theta Cordance Predicts 6-Month Antidepressant Response to Subcallosal Cingulate Deep Brain Stimulation for Treatment-Resistant Depression: A Pilot Study. Neuropsychopharmacology 2012,
71. Ray CD, Burton CV. Deep brain stimulation for severe, chronic pain. Acta Neurochir Suppl 1980, 30:289-293. 10.1007/978-3-7091-8592-6_35, 7008523.
72. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Sci 1990, 249(4975):1436-1438.
73. Hubble JP, Busenbark KL, Wilkinson S, Penn RD, Lyons K, Koller WC. Deep brain stimulation for essential tremor. Neurol 1996, 46(4):1150-1153.
74. Krauss JK. Deep brain stimulation for cervical dystonia. J Neurol Neurosurg Psychiatry 2003, 74(11):1598. 10.1136/jnnp.74.11.1598, 1738222, 14617734.
75. Aouizerate B, Martin-Guehl C, Cuny E, Guehl D, Amieva H, Benazzouz A, Fabrigoule C, Bioulac B, Tignol J, Burbaud P. Deep brain stimulation for OCD and major depression. Am J Psychiatry 2005, 162(11):2192.
76. Malone DA, Pandya MM. Behavioral neurosurgery. Adv Neurol 2006, 99:241-247.
77. Soreq L, Bergman H, Goll Y, Greenberg DS, Israel Z, Soreq H. Deep brain stimulation induces rapidly reversible transcript changes in Parkinson's leucocytes. J Cell Mol Med 2012, 16(7):1496-1507. 10.1111/j.1582-4934.2011.01444.x, 21910823.
78. Clark TA, Sugnet CW, Ares M. Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Sci 2002, 296(5569):907.
79. Srinivasan K, Shiue L, Hayes JD, Centers R, Fitzwater S, Loewen R, Edmondson LR, Bryant J, Smith M, Rommelfanger C. Detection and measurement of alternative splicing using splicing-sensitive microarrays. Methods 2005, 37(4):345-359. 10.1016/j.ymeth.2005.09.007, 16314264.
80. da Huang W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 2009, 4(1):44-57.
81. da Huang W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 2009, 37(1):1-13. 10.1093/nar/gkn923, 2615629, 19033363.
82. Harris MA, Clark J, Ireland A, Lomax J, Ashburner M, Foulger R, Eilbeck K, Lewis S, Marshall B, Mungall C, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res 2004, 32(Database issue):D258-261. 308770, 14681407.
83. Kanehisa M. The KEGG database. Novartis Found Symp 2002, 247:91-101. discussion 101-103, 119-128, 244-152.
84. McMillan LE, Martin AC. Automatically extracting functionally equivalent proteins from SwissProt. BMC Bioinforma 2008, 9:418.
85. Apweiler R, Attwood TK, Bairoch A, Bateman A, Birney E, Biswas M, Bucher P, Cerutti L, Corpet F, Croning MD, et al. The InterPro database, an integrated documentation resource for protein families, domains and functional sites. Nucleic Acids Res 2001, 29(1):37-40. 10.1093/nar/29.1.37, 29841, 11125043.